Prion protein in Caenorhabditis elegans

References

• Aguzzi A, Heikenwalder M. Pathogenesis of prion diseases: current status and future outlook. Nat Rev Microbiol 2006; 4:765 - 775
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science 1982; 216:136 - 144
   PubMed Web of Science ®Google Scholar
• Bendheim PE, Marmorstein AD, Potempska A, Bolton DC. Scrapie agent proteins do not accumulate in grey tremor mice. J Gen Virol 1988; 69:961 - 966
   PubMed Web of Science ®Google Scholar
• Kretzschmar HA, Stowring LE, Westaway D, Stubblebine WH, Prusiner SB, Dearmond SJ. Molecular cloning of a human prion protein cDNA. DNA 1986; 5:315 - 324
   PubMedGoogle Scholar
• Manson J, West JD, Thomson V, McBride P, Kaufman MH, Hope J. The prion protein gene: a role in mouse embryogenesis?. Development 1992; 115:117 - 122
   PubMed Web of Science ®Google Scholar
• Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. Mice devoid of PrP are resistant to scrapie. Cell 1993; 73:1339 - 1347
   PubMed Web of Science ®Google Scholar
• Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, DeArmond SJ, et al. Synthetic mammalian prions. Science 2004; 305:673 - 676
   PubMed Web of Science ®Google Scholar
• Wang F, Wang X, Yuan CG, Ma J. Generating a prion with bacterially expressed recombinant prion protein. Science 2010; 327:1132 - 1135
   PubMed Web of Science ®Google Scholar
• Cobb NJ, Surewicz WK. Prion diseases and their biochemical mechanisms. Biochemistry 2009; 48:2574 - 2585
   PubMed Web of Science ®Google Scholar
• Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005; 308:1435 - 1439
   PubMed Web of Science ®Google Scholar
• Chiesa R, Piccardo P, Quaglio E, Drisaldi B, Si-Hoe SL, Takao M, et al. Molecular distinction between pathogenic and infectious properties of the prion protein. J Virol 2003; 77:7611 - 7622
   PubMed Web of Science ®Google Scholar
• Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125. EMBO J 2007; 26:548 - 558
   PubMed Web of Science ®Google Scholar
• Solomon IH, Schepker JA, Harris DA. Prion neurotoxicity: Insights from prion protein mutants. Curr Issues Mol Biol 2009; 12:51 - 62
   PubMed Web of Science ®Google Scholar
• Chiesa R, Piccardo P, Biasini E, Ghetti B, Harris DA. Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities. J Neurosci 2008; 28:13258 - 13267
   PubMed Web of Science ®Google Scholar
• Westergard L, Christensen HM, Harris DA. The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta 2007; 1772:629 - 644
   PubMed Web of Science ®Google Scholar
• Aguzzi A, Sigurdson C, Heikenwaelder M. Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008; 3:11 - 40
   PubMed Web of Science ®Google Scholar
• Kuwahara C, Takeuchi AM, Nishimura T, Haraguchi K, Kubosaki A, Matsumoto Y, et al. Prions prevent neuronal cell-line death. Nature 1999; 400:225 - 226
   PubMed Web of Science ®Google Scholar
• Bounhar Y, Zhang Y, Goodyer CG, LeBlanc A. Prion protein protects human neurons against Bax-mediated apoptosis. J Biol Chem 2001; 276:39145 - 39149
   PubMed Web of Science ®Google Scholar
• Flechsig E, Hegyi I, Leimeroth R, Zuniga A, Rossi D, Cozzio A, et al. Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia. EMBO J 2003; 22:3095 - 3101
   PubMed Web of Science ®Google Scholar
• Bounhar Y, Mann KK, Roucou X, LeBlanc AC. Prion protein prevents Bax-mediated cell death in the absence of other Bcl-2 family members in Saccharomyces cerevisiae. FEMS Yeast Res 2006; 6:1204 - 1212
   PubMed Web of Science ®Google Scholar
• Li A, Dong J, Harris DA. Cell surface expression of the prion protein in yeast does not alter copper utilization phenotypes. J Biol Chem 2004; 279:29469 - 29477
   PubMed Web of Science ®Google Scholar
• Fernandez-Funez P, Casas-Tinto S, Zhang Y, Gomez-Velazquez M, Morales-Garza MA, Cepeda-Nieto AC, et al. In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms. PLoS Genet 2009; 5:e1000507
   PubMed Web of Science ®Google Scholar
• Gavin BA, Dolph MJ, Deleault NR, Geoghegan JC, Khurana V, Feany MB, et al. Accelerated accumulation of misfolded prion protein and spongiform degeneration in a Drosophila model of Gerstmann-Straussler-Scheinker syndrome. J Neurosci 2006; 26:12408 - 12414
   PubMed Web of Science ®Google Scholar
• Raeber AJ, Muramoto T, Kornberg TB, Prusiner SB. Expression and targeting of Syrian hamster prion protein induced by heat shock in transgenic Drosophila melanogaster. Mech Dev 1995; 51:317 - 327
   PubMed Web of Science ®Google Scholar
• Bizat N, Peyrin JM, Haik S, Cochois V, Beaudry P, Laplanche JL, et al. Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. J Neurosci 2010; 30:5394 - 5403
   Google Scholar
• Park KW, Li L. Cytoplasmic expression of mouse prion protein causes severe toxicity in Caenorhabditis elegans. Biochem Biophys Res Commun 2008; 372:697 - 702
   PubMed Web of Science ®Google Scholar
• Gengyo-Ando K, Mitani S. Characterization of mutations induced by ethyl methanesulfonate, UV and trimethylpsoralen in the nematode Caenorhabditis elegans. Biochem Biophys Res Commun 2000; 269:64 - 69
   PubMed Web of Science ®Google Scholar
• Ma J, Lindquist S. De novo generation of a PrPSc-like conformation in living cells. Nat Cell Biol 1999; 1:358 - 361
   PubMed Web of Science ®Google Scholar
• Nass R, Hall DH, Miller DM 3rd, Blakely RD. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans. Proc Natl Acad Sci USA 2002; 99:3264 - 3269
   PubMed Web of Science ®Google Scholar
• Duerr JS, Frisby DL, Gaskin J, Duke A, Asermely K, Huddleston D, et al. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J Neurosci 1999; 19:72 - 84
   PubMed Web of Science ®Google Scholar
• Taub J, Lau JF, Ma C, Hahn JH, Hoque R, Rothblatt J, et al. A cytosolic catalase is needed to extend adult lifespan in C. elegans daf-C and clk-1 mutants. Nature 2003; 421:764
   PubMed Web of Science ®Google Scholar
• Sawin ER, Ranganathan R, Horvitz HR. C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron 2000; 26:619 - 631
   PubMed Web of Science ®Google Scholar
• Locht C, Chesebro B, Race R, Keith JM. Molecular cloning and complete sequence of prion protein cDNA from mouse brain infected with the scrapie agent. Proc Natl Acad Sci USA 1986; 83:6372 - 6376
   PubMed Web of Science ®Google Scholar
• Stahl N, Borchelt DR, Hsiao K, Prusiner SB. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 1987; 51:229 - 240
   PubMed Web of Science ®Google Scholar
• Stimson E, Hope J, Chong A, Burlingame AL. Site-specific characterization of the N-linked glycans of murine prion protein by high-performance liquid chromatography/electrospray mass spectrometry and exoglycosidase digestions. Biochemistry 1999; 38:4885 - 4895
   PubMed Web of Science ®Google Scholar
• Kraemer BC, Zhang B, Leverenz JB, Thomas JH, Trojanowski JQ, Schellenberg GD. Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci USA 2003; 100:9980 - 9985
   PubMed Web of Science ®Google Scholar
• Anderson P, Brenner S. A selection for myosin heavy chain mutants in the nematode Caenorhabditis elegans. Proc Natl Acad Sci USA 1984; 81:4470 - 4474
   PubMed Web of Science ®Google Scholar
• Kindt KS, Quast KB, Giles AC, De S, Hendrey D, Nicastro I, et al. Dopamine mediates context-dependent modulation of sensory plasticity in C. elegans. Neuron 2007; 55:662 - 676
   PubMed Web of Science ®Google Scholar
• Sulston J, Dew M, Brenner S. Dopaminergic neurons in the nematode Caenorhabditis elegans. J Comp Neurol 1975; 163:215 - 226
   PubMed Web of Science ®Google Scholar
• Ma J, Wollmann R, Lindquist S. Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol. Science 2002; 298:1781 - 1785
   PubMed Web of Science ®Google Scholar
• Huang S, Liang J, Zheng M, Li X, Wang M, Wang P, et al. Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice. Proc Natl Acad Sci USA 2007; 104:6800 - 6805
   PubMed Web of Science ®Google Scholar
• Sarkozi E, Askanas V, Engel WK. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy. Am J Pathol 1994; 145:1280 - 1284
   PubMed Web of Science ®Google Scholar
• Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R, et al. The cellular prion protein binds copper in vivo. Nature 1997; 390:684 - 687
   PubMed Web of Science ®Google Scholar
• Singh A, Kong Q, Luo X, Petersen RB, Meyerson H, Singh N. Prion protein (PrP) knock-out mice show altered iron metabolism: a functional role for PrP in iron uptake and transport. PLoS ONE 2009; 4:e6115
   PubMed Web of Science ®Google Scholar
• Taylor DR, Hooper NM. The prion protein and lipid rafts. Mol Membr Biol 2006; 23:89 - 99
   PubMed Web of Science ®Google Scholar
• Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, et al. Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 2001; 314:1209 - 1225
   PubMed Web of Science ®Google Scholar
• Jeffrey M, McGovern G, Goodsir CM, Brown KL, Bruce ME. Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy. J Pathol 2000; 191:323 - 332
   PubMed Web of Science ®Google Scholar
• Milhavet O, Lehmann S. Oxidative stress and the prion protein in transmissible spongiform encephalopathies. Brain Res Brain Res Rev 2002; 38:328 - 339
   PubMed Web of Science ®Google Scholar
• Ellis HM, Horvitz HR. Genetic control of programmed cell death in the nematode C. elegans. Cell 1986; 44:817 - 829
   PubMed Web of Science ®Google Scholar
• Hengartner MO, Ellis RE, Horvitz HR. Caenorhabditis elegans gene ced-9 protects cells from programmed cell death. Nature 1992; 356:494 - 499
   PubMed Web of Science ®Google Scholar
• Chinnaiyan AM, O'Rourke K, Lane BR, Dixit VM. Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science 1997; 275:1122 - 1126
   PubMed Web of Science ®Google Scholar
• Hengartner MO. Programmed cell death in invertebrates. Curr Opin Genet Dev 1996; 6:34 - 38
   PubMed Web of Science ®Google Scholar
• Lomonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008; 27:2 - 19
   PubMed Web of Science ®Google Scholar
• Strasser A, O'Connor L, Dixit VM. Apoptosis signaling. Annu Rev Biochem 2000; 69:217 - 245
   PubMed Web of Science ®Google Scholar
• Jagasia R, Grote P, Westermann B, Conradt B. DRP-1-mediated mitochondrial fragmentation during EGL-1-induced cell death in C. elegans. Nature 2005; 433:754 - 760
   PubMed Web of Science ®Google Scholar
• Li A, Harris DA. Mammalian prion protein suppresses Bax-induced cell death in yeast. J Biol Chem 2005; 280:17430 - 17434
   PubMed Web of Science ®Google Scholar
• Roucou X, Guo Q, Zhang Y, Goodyer CG, LeBlanc AC. Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J Biol Chem 2003; 278:40877 - 40881
   PubMed Web of Science ®Google Scholar